Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.55 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | CASP2 | P42575 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.31 |
| ▸ | RAD52 | P43351 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyridine SCHEMBL988718 | 0.93 | TSHR (0.55) | TSHRTDP1NAPRTALDH1A1CYP2D6 | |
| Pyridine SCHEMBL2762938 | 0.91 | TSHR (0.59) | TSHRTDP1NAPRTALDH1A1L3MBTL1 | |
| Pyridine SCHEMBL3912001 | 0.91 | TSHR (0.59) | TSHRTDP1NAPRTALDH1A1L3MBTL1 | |
| Pyridine SCHEMBL43361 | 0.91 | TSHR (0.59) | TSHRTDP1NAPRTALDH1A1L3MBTL1 | |
| Pyridine SCHEMBL160900 | 0.91 | TSHR (0.59) | TSHRTDP1NAPRTALDH1A1L3MBTL1 | |
| Pyridine SCHEMBL313836 | 0.91 | TSHR (0.59) | TSHRTDP1NAPRTALDH1A1L3MBTL1 | |
| Pyridine SCHEMBL1258383 | 0.91 | TSHR (0.59) | TSHRTDP1NAPRTALDH1A1L3MBTL1 | |
| Pyridine SCHEMBL7142445 | 0.91 | TSHR (0.59) | TSHRTDP1NAPRTALDH1A1L3MBTL1 | |
| Pyridine SCHEMBL21641467 | 0.91 | TSHR (0.59) | TSHRTDP1NAPRTALDH1A1L3MBTL1 | |
| Pyridine SCHEMBL1389613 | 0.91 | TSHR (0.59) | TSHRTDP1NAPRTALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 479 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106964345-B | A kind of noble metal porous nano film and preparation method thereof | 武汉理工大学 | 2019-08-27 | — | — | CN | claimed |
| CN-106964345-A | A kind of noble metal porous nano film and preparation method thereof | 武汉理工大学 | 2017-07-21 | — | — | CN | claimed |
| CN-104911650-A | Novel electroplating solution for gallium plating | LIANG SHENGGUANG | 2015-09-16 | — | — | CN | claimed |
| US-8715853-B1 | Aluminum batteries comprising metal-oxide, metal-fluoride, metal-sulfide, or sulfur cathodes | HRL LABORATORIES, LLC (US) | 2014-05-06 | — | — | US | claimed |
| US-20120136189-A1 | BUFFERED IONIC LIQUIDS FOR OLEFIN DIMERIZATION | CONOCOPHILLIPS COMPANY - IP SERVICES GROUP (US) | 2012-05-31 | — | — | US | claimed |
| WO-2011112514-A1 | BUFFERED IONIC LIQUIDS FOR OLEFIN DIMERIZATION | CONOCOPHILLIPS COMPANY (US) | 2011-09-15 | — | — | WO | claimed |
| US-20110185788-A1 | IONIC LIQUIDS AS SOLVENTS IN HEADSPACE GAS CHROMATOGRAPHY | KOCH PETER | 2011-08-04 | — | — | US | claimed |
| EP-2275090-A2 | Microparticles prepared using an ionic liquid | Novartis AG (CH) | 2011-01-19 | — | — | EP | claimed |
| US-20100239524-A1 | MICROPARTICLES PREPARED USING AN IONIC LIQUID | NOVARTIS AG (CH) | 2010-09-23 | — | — | US | claimed |
| US-7569149-B2 | Ionic liquids as solvents in headspace gas chromatography | NOVARTIS AG (CH) | 2009-08-04 | — | — | US | claimed |
| US-5994602-A | IN THE PRESENCE OF A HYDROCARBYL ALUMINUM OR GALLIUM HALIDE AND A HYDROCARBYL-SUBSTITUTED IMIDAZOLIUM OR PYRIDINIUM HALIDE | BP CHEMICALS LIMITED (GB) | 1999-11-30 | — | — | US | claimed |
| WO-1998047616-A1 | CATALYST COMPRISING A BUFFERED IONIC LIQUID AND HYDROCARBON CONVERSION PROCESS, E.G. OLIGOMERISATION | BP CHEMICALS LIMITED (GB) | 1998-10-29 | — | — | WO | claimed |
| EP-0693045-B1 | ALKYLATION PROCESS | BP CHEM INT LTD (GB) | 1997-10-22 | — | — | EP | claimed |
| EP-0791643-A1 | Lubricating oils | BP Chemicals Limited (GB) | 1997-08-27 | — | — | EP | claimed |
| US-5643490-A | HETEROCYCLIC CATIONIC POLYMER FOR ELECTROLYTES | SONY CORPORATION (JP) | 1997-07-01 | — | — | US | claimed |
| US-5550306-A | Catalytic process for the dimerization of olefins | INSTITUT FRANCAIS DU PETROLE (FR) | 1996-08-27 | — | — | US | claimed |
| EP-0693045-A1 | ALKYLATION PROCESS | BP CHEM INT LTD (GB) | 1996-01-24 | — | — | EP | claimed |
| WO-1995021872-A1 | IONIC LIQUIDS | BP CHEMICALS LIMITED (GB) | 1995-08-17 | — | — | WO | claimed |
| WO-1995021806-A1 | ALKYLATION PROCESS | BP CHEMICALS LIMITED (GB) | 1995-08-17 | — | — | WO | claimed |
| US-4355086-A | IMPROVED WITH ALUMINUM CHLORIDE AND BUTYL PYRIDINIUM CHLORIDE | HONEYWELL INC. (US) | 1982-10-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100239524-A1 | MICROPARTICLES PREPARED USING AN IONIC LIQUID | FIBP, MIF, CHMP4B | TSHR 3760/4885TDP1 1587/4885NAPRT 4128/4885 |
| US-20120136189-A1 | BUFFERED IONIC LIQUIDS FOR OLEFIN DIMERIZATION | OSBPL8, OSBP, OSBP2 | TSHR 2589/4885TDP1 2022/4885NAPRT 2710/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.